🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1994-06
Trial ID
NCT00002571
This is a interventional phase II study aiming to examine the complete resp...
Status
Recruiting
Location
Instituto do Cancer do Estado de Sao Paulo
Start Date
2024-04-01
Trial ID
NCT06034561
Treatments Being Tested
The goal of this clinical research study is to learn if a chemotherapy comb...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-11-13
Trial ID
NCT02419469
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
Pilot study to determine feasibility of adding intrathecal chemotherapy and...
Status
Recruiting
Location
Alberta Children's Hospital
Start Date
2025-09-23
Trial ID
NCT06942039
Leukemia cells grow and divide fast and out of control. In normal cells, ce...
Status
Terminated
Location
St. Jude Children's Research Hospital
Start Date
2018-04-20
Trial ID
NCT03515200
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Withdrawn
Location
Pediatric Oncology Branch
Start Date
1999-10
Trial ID
NCT00019409
AINV18P1 is a Phase 1 study where palbociclib will be administrated in comb...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2019-04-11
Trial ID
NCT03792256